Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Muirhead

Showing results (21-30 of 70) with videos related to

Pageof 7
Sort By:
Tissue Antigens|January 11, 2007
Kappa immunoglobulin light chain polymorphisms and survival after allogeneic transplantation for B-cell malignancies: a potential graft-vs-leukaemia targetT L Etto, L A Stewart, J Muirhead, et al.
British Journal of Clinical Pharmacology|March 26, 2008
The effects of cotrimoxazole or tenofovir co-administration on the pharmacokinetics of maraviroc in healthy volunteersSamantha Abel, Deborah Russell, Lyndsey A Whitlock, et al.
British Journal of Clinical Pharmacology|March 1, 1995
Population pharmacodynamics of romazaritN H Holford, P E Williams, G J Muirhead, et al.
British Journal of Clinical Pharmacology|April 20, 2000
Ziprasidone and the pharmacokinetics of a combined oral contraceptiveG J Muirhead, J Harness, P R Holt, et al.
British Journal of Clinical Pharmacology|March 26, 2008
Effect of maraviroc on the pharmacokinetics of midazolam, lamivudine/zidovudine, and ethinyloestradiol/levonorgestrel in healthy volunteersSamantha Abel, Deborah Russell, Lyndsey A Whitlock, et al.
British Journal of Clinical Pharmacology|March 26, 2008
A novel probe drug interaction study to investigate the effect of selected antiretroviral combinations on the pharmacokinetics of a single oral dose of maraviroc in HIV-positive subjectsAnton L Pozniak, Marta Boffito, Deborah Russell, et al.
Cytotherapy|September 21, 2007
Intermediate-dose CY and G-CSF more efficiently mobilize adequate numbers of PBSC for tandem autologous PBSC transplantation compared with low-dose CY in patients with multiple myelomaD K Hiwase, G Bollard, S Hiwase, et al.
British Journal of Clinical Pharmacology|March 26, 2008
Effects of CYP3A4 inhibitors on the pharmacokinetics of maraviroc in healthy volunteersSamantha Abel, Deborah Russell, Richard J Taylor-Worth, et al.
British Journal of Clinical Pharmacology|March 26, 2008
Effects of CYP3A4 inducers with and without CYP3A4 inhibitors on the pharmacokinetics of maraviroc in healthy volunteersSamantha Abel, Timothy M Jenkins, Lyndsey A Whitlock, et al.
The Journal of Thoracic and Cardiovascular Surgery|October 1, 1982
Repair of atrioventricular canal malformation in the first year of lifeH W Bender, J W Hammon, S G Hubbard, et al.
Pageof 7

Showing results (21-30 of 70) with videos related to

Sort By:
Pageof 7
Tissue Antigens|January 11, 2007
Kappa immunoglobulin light chain polymorphisms and survival after allogeneic transplantation for B-cell malignancies: a potential graft-vs-leukaemia targetT L Etto, L A Stewart, J Muirhead, et al.
British Journal of Clinical Pharmacology|March 26, 2008
The effects of cotrimoxazole or tenofovir co-administration on the pharmacokinetics of maraviroc in healthy volunteersSamantha Abel, Deborah Russell, Lyndsey A Whitlock, et al.
British Journal of Clinical Pharmacology|March 1, 1995
Population pharmacodynamics of romazaritN H Holford, P E Williams, G J Muirhead, et al.
British Journal of Clinical Pharmacology|April 20, 2000
Ziprasidone and the pharmacokinetics of a combined oral contraceptiveG J Muirhead, J Harness, P R Holt, et al.
British Journal of Clinical Pharmacology|March 26, 2008
Effect of maraviroc on the pharmacokinetics of midazolam, lamivudine/zidovudine, and ethinyloestradiol/levonorgestrel in healthy volunteersSamantha Abel, Deborah Russell, Lyndsey A Whitlock, et al.
British Journal of Clinical Pharmacology|March 26, 2008
A novel probe drug interaction study to investigate the effect of selected antiretroviral combinations on the pharmacokinetics of a single oral dose of maraviroc in HIV-positive subjectsAnton L Pozniak, Marta Boffito, Deborah Russell, et al.
Cytotherapy|September 21, 2007
Intermediate-dose CY and G-CSF more efficiently mobilize adequate numbers of PBSC for tandem autologous PBSC transplantation compared with low-dose CY in patients with multiple myelomaD K Hiwase, G Bollard, S Hiwase, et al.
British Journal of Clinical Pharmacology|March 26, 2008
Effects of CYP3A4 inhibitors on the pharmacokinetics of maraviroc in healthy volunteersSamantha Abel, Deborah Russell, Richard J Taylor-Worth, et al.
British Journal of Clinical Pharmacology|March 26, 2008
Effects of CYP3A4 inducers with and without CYP3A4 inhibitors on the pharmacokinetics of maraviroc in healthy volunteersSamantha Abel, Timothy M Jenkins, Lyndsey A Whitlock, et al.
The Journal of Thoracic and Cardiovascular Surgery|October 1, 1982
Repair of atrioventricular canal malformation in the first year of lifeH W Bender, J W Hammon, S G Hubbard, et al.
Pageof 7